Janus Henderson Group
CGON icon

Janus Henderson Group’s CG Oncology CGON Stock Holding History

Janus Henderson Group’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.25M Hold
18,500
– – ﹤0.01% 1585
2025
Q4 		$769K Hold
18,500
– – ﹤0.01% 1815
2025
Q3 		$745K Hold
18,500
– – ﹤0.01% 1810
2025
Q2 		$481K Sell
18,500
-1,259,241
-99% -$30.3M ﹤0.01% 1976
2025
Q1 		$33.7M Sell
1,277,741
-208,102
-14% -$5.85M 0.02% 450
2024
Q4 		$42.6M Sell
1,485,843
-40,691
-3% -$1.39M 0.02% 412
2024
Q3 		$51.9M Buy
1,526,534
+99,517
+7% +$3.49M 0.03% 381
2024
Q2 		$45M Sell
1,427,017
-94,415
-6% -$3.27M 0.02% 403
2024
Q1 		$66.8M Buy
+1,521,432
New +$62.1M 0.04% 329

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Janus Henderson Group's CGON Position: Q1 2026 in Review

Janus Henderson Group held its CG Oncology (CGON) position steady in Q1 2026 at 18,500 shares worth $1.25M. The position accounts for ﹤0.01% of the portfolio, ranked #1585.

Janus Henderson Group first reported a position in CGON in Q1 2024 and has held it in 9 quarters since. The position peaked at $66.8M in Q1 2024. 233 funds tracked by Wall St. Rank hold CGON as of Q1 2026.

  • Janus Henderson Group held 18,500 shares of CG Oncology worth $1.25M as of Q1 2026.
  • Janus Henderson Group left its CG Oncology share count unchanged in Q1 2026.
  • CG Oncology made up ﹤0.01% of Janus Henderson Group's portfolio in Q1 2026, its #1585 holding.
  • Janus Henderson Group first reported a position in CG Oncology in Q1 2024 and has held it in 9 quarters since.
  • Janus Henderson Group's CG Oncology position peaked at $66.8M in Q1 2024.
  • 233 funds tracked by Wall St. Rank held CG Oncology as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.